Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia

Recruiting N/A Interventional Study
Patient Satisfaction
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
140 (estimated)
Sponsor
Beni-Suef University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to fill the knowledge gap by investigating the predictors of success for TPVB in patients with herpetic neuralgia. By identifying demographic, clinical, previous medications and procedural factors associated with positive outcomes, this research seeks to enhance the efficacy of TPVB and improve pain management strategies for patients suffering from herpetic neuralgia.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged from18 to 70 years * Diagnosed with herpetic neuralgia. * Able and willing to provide informed consent. * ASA I - II * One dermatomal affection * Thoracic distribution Exclusion Criteria: * Contraindications to TPVB as ( Infection at site of injection, empyema , …
Contacts

Dina M Fakhry, MD

+201289998680

drdina.mahmoud@med.bsu.edu.eg

CONTACT